The Food and Drug Administration plans to survey compounding pharmacies that make specialized copies of prescription drugs ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Bread and rolls sold in six states have been recalled over 'glass fragments,' according to the U.S. Food and Drug ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

On April 22, 2025, the U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) announced a series of ...

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

The Food and Drug Administration (FDA) announced actions Tuesday to phase out the use of petroleum-based food dyes in U.S.

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

The US Food and Drug Administration plans to phase out the use of petroleum-based synthetic dyes in the US food supply due to ...